Perspective Therapeutics (CATX) Total Current Liabilities (2011 - 2026)

Perspective Therapeutics' Total Current Liabilities history runs 16 years deep, the most recent figure standing at $31.5 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 148.33% year-over-year to $31.5 million; the TTM figure through Mar 2026 stood at $31.5 million (up 148.33% YoY), while the FY2025 annual figure was $28.7 million, up 57.32% from the prior year.
• Total Current Liabilities came in at $31.5 million for Q1 2026 at Perspective Therapeutics, up from $28.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $31.5 million in Q1 2026 to a low of $2.0 million in Q1 2022.
• A 5-year average of $13.5 million and a median of $12.7 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities jumped 402.37% in 2023 and retreated 26.74% in 2025, its largest moves.
• Perspective Therapeutics' Total Current Liabilities stood at $3.1 million in 2022, then surged by 402.37% to $15.7 million in 2023, then gained by 16.38% to $18.2 million in 2024, then soared by 57.32% to $28.7 million in 2025, then advanced by 9.79% to $31.5 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $31.5 million, $28.7 million, and $20.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison